Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances

European Journal of Clinical Investigation

Volumn 43, Issue 2, 2013, Pages 183-189

  Al Daghri, Nasser M ^a,b   Al Attas, Omar S ^a,b   Alokail, Majed S ^a,b   Alkharfy, Khalid M ^a,b,c   Charalampidis, Paris ^d   Livadas, Sarantis ^d   Kollias, Anastasios ^d   Sabico, Shaun Louie ^a   Chrousos, George P ^a,d  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Adiponectin; Adipose; Visceral adiposity index

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GENDER; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VISCERAL ADIPOSITY INDEX; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADIPOSE TISSUE; ADIPOSITY; ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; FEMALE; GLUCOSE METABOLISM DISORDERS; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RESISTIN; SAUDI ARABIA; SEX FACTORS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84872616581     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12030     Document Type: Article

References (26)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;72:425-32.
2. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab
3. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yakout SM, Sabico SB, Gibson GC, Chrousos GP, Kumar S. Parent-offspring transmission of adipocytokine levels and their associations with metabolic traits. PLoS One
4. Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care
5. Tschritter O, Fritsche A, Thamer C. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes
6. Wei M, Gaskill SP, Haffner SM, Stern MP. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared with body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans: a 7-year prospective study. Obes Res
7. Kashihara H, Lee J, Kawakubo K, Tamura M, Akabayashi A. Criteria of waist circumference according to computed tomographymeasured visceral fat area and the clustering of cardiovascular risk factors. Circ J
8. Bonora E, Targher G, Alberiche M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care
9. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A. Group ftAS: visceral adiposity index. Diabetes Care 2010;33:920-2.
10. Amato MC, Verghi M, Galluzzo A, Giordano C. The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk. Hum Reprod 2011;26:1486-94.
11. Petta S, Amato M, Cabibi D, Camma C, Di Marco V, Giordano C, Galluzzo A, Craxi A. Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Hepatology 2010;52:1543-52.
12. Ciresi A, Amato MC, Pizzolanti G, Galluzzo CG: Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. J Clin Endocrinol Metab 2012;97:2907-15.
13. Amato MC, Giordano C, Pitrone M, Galluzzo A. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis 2011;10:183.
14. Bozorgmanesh M, Hadaegh F, Azizi F. Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes. Lipids Health Dis 2011;10:88.
15. Mohammadreza B, Farzad H, Davoud K, Prof AF. Prognostic significance of the complex "Visceral Adiposity Index" vs. simple anthropometric measures: tehran lipid and glucose study. Cardiovasc Diabetol 2012;7:20.
16. Umeda M, Ichikawa SC, Kanda T, Sumino H, Kobayashi I. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women. Am J Hypertens 2001;14: 206-11.
17. DeNino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK, Poehlman ET. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001;24:925-32.
18. Rader DJ. Effect of insulin resistance, dyslipidemia, and intraabdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 2007;120:S12-8.
19. Despres JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med 2006;38:52-63.
20. Taksali SE, Caprio S, Dziura J, Dufour S, Calí AM, Goodman TR, Papademetris X, Burgert TS, Pierpont BM, Savoye M, Shaw M, Seyal AA, Weiss R: High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype
21. Bjorntorp P. Metabolic difference between visceral fat and subcutaneous abdominal fat. Diabetes Metab 2000;26:10-2.
22. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Sabico SLS, Chrousos GP. Diabetes mellitus type 2 and other chronic noncommunicable diseases in the central region, Saudi Arabia (Riyadh Cohort 2): a decade of an epidemic. BMC Med 2011;9:76.
23. Spranger J, Kroke A, Mohlig M. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;361:226-8.
24. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26:439-51.
25. Cote Ḿ, Mauriege P, Bergeron J, Almeras N, Tremblay A, Lemieux I, Despres JP: Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab 2005; 90:1434-9.
26. Al-Daghri NM, Al-Attas OS, Al-Onazi M, Al-Rubeaan K, Al-Najjar H. Adipocytokines as influenced by family history of type 2 diabetes and smoking in non-diabetic subjects. Clin Med Insights Endocrinol Diabetes 2008;1:13-9.